questionsmedicales.fr
Techniques d'investigation
Techniques de laboratoire clinique
Techniques microbiologiques
Culture virale
Culture virale : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Culture virale
Diagnostic viral
Échantillons biologiques
Culture virale
Tests de laboratoire
Diagnostic viral
Culture virale
Temps de culture
Infection virale
Culture virale
Symptômes
5
Symptômes
Infection virale
Réponse immunitaire
Infection virale
Asymptomatique
Culture virale
Urgence médicale
Culture virale
Traitements
5
Antiviraux
Traitement antiviral
Culture virale
Traitement antiviral
Antibiotiques
Infection virale
Antiviraux
Réponse immunitaire
Virus
Traitement antiviral
Complications
5
Complications
Infection virale
Complications
État de santé
Personnes âgées
Complications
Facteurs de risque
5
Facteurs de risque
Infection virale
Maladies chroniques
Facteurs de risque
Mode de vie
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Culture virale : Questions médicales les plus fréquentes",
"headline": "Culture virale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Culture virale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-13",
"dateModified": "2025-03-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Culture virale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Techniques microbiologiques",
"url": "https://questionsmedicales.fr/mesh/D008828",
"about": {
"@type": "MedicalCondition",
"name": "Techniques microbiologiques",
"code": {
"@type": "MedicalCode",
"code": "D008828",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.875"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Méthode des plages virales",
"alternateName": "Viral Plaque Assay",
"url": "https://questionsmedicales.fr/mesh/D010948",
"about": {
"@type": "MedicalCondition",
"name": "Méthode des plages virales",
"code": {
"@type": "MedicalCode",
"code": "D010948",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.875.970.790"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Culture virale",
"alternateName": "Virus Cultivation",
"code": {
"@type": "MedicalCode",
"code": "D014776",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Arvind Varsani",
"url": "https://questionsmedicales.fr/author/Arvind%20Varsani",
"affiliation": {
"@type": "Organization",
"name": "2The Biodesign Center of Fundamental and Applied Microbiomics, School of Life Sciences, Center for Evolution and Medicine, Arizona State University, 1001 S. McAllister Ave, Tempe, AZ 85287-5001 USA."
}
},
{
"@type": "Person",
"name": "Giacomo Fais",
"url": "https://questionsmedicales.fr/author/Giacomo%20Fais",
"affiliation": {
"@type": "Organization",
"name": "Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy."
}
},
{
"@type": "Person",
"name": "Mattia Casula",
"url": "https://questionsmedicales.fr/author/Mattia%20Casula",
"affiliation": {
"@type": "Organization",
"name": "Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy."
}
},
{
"@type": "Person",
"name": "Pierluigi Caboni",
"url": "https://questionsmedicales.fr/author/Pierluigi%20Caboni",
"affiliation": {
"@type": "Organization",
"name": "Department of Life and Environmental Sciences, University of Cagliari, 09042 Cagliari, Italy."
}
},
{
"@type": "Person",
"name": "Giacomo Cao",
"url": "https://questionsmedicales.fr/author/Giacomo%20Cao",
"affiliation": {
"@type": "Organization",
"name": "Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Utilization Management in the Medicare Part D Program and Prescription Drug Utilization.",
"datePublished": "2022-10-04",
"url": "https://questionsmedicales.fr/article/36194915",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1515/fhep-2022-0007"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sedative drug-use in Denmark, 2000 to 2019: a nationwide drug utilization study.",
"datePublished": "2022-12-23",
"url": "https://questionsmedicales.fr/article/36562827",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00127-022-02409-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impact of supply chain disruptions and drug shortages on drug utilization: A scoping review protocol.",
"datePublished": "2024-11-01",
"url": "https://questionsmedicales.fr/article/39485772",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0313298"
}
},
{
"@type": "ScholarlyArticle",
"name": "Opioid prescriber responsibility: A Danish drug utilization study.",
"datePublished": "2022-11-29",
"url": "https://questionsmedicales.fr/article/36366867",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/bcp.15595"
}
},
{
"@type": "ScholarlyArticle",
"name": "Inequality in Drug Utilization among Chronic Myeloid Leukaemia Patients in Malaysia: A Cost-Utility Analysis.",
"datePublished": "2022-12-01",
"url": "https://questionsmedicales.fr/article/36580008",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.31557/APJCP.2022.23.12.4253"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Techniques d'investigation",
"item": "https://questionsmedicales.fr/mesh/D008919"
},
{
"@type": "ListItem",
"position": 3,
"name": "Techniques de laboratoire clinique",
"item": "https://questionsmedicales.fr/mesh/D019411"
},
{
"@type": "ListItem",
"position": 4,
"name": "Techniques microbiologiques",
"item": "https://questionsmedicales.fr/mesh/D008828"
},
{
"@type": "ListItem",
"position": 5,
"name": "Culture virale",
"item": "https://questionsmedicales.fr/mesh/D014776"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Culture virale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Culture virale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Culture virale",
"description": "Comment se déroule un test de culture virale ?\nQuels échantillons sont utilisés pour la culture virale ?\nQuels tests complètent la culture virale ?\nCombien de temps prend une culture virale ?\nQuels signes indiquent une infection virale dans une culture ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Drug+Utilization#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Culture virale",
"description": "Quels symptômes peuvent indiquer une infection virale ?\nLes symptômes varient selon le virus ?\nComment les symptômes évoluent-ils avec une infection virale ?\nLes symptômes sont-ils toujours présents lors d'une culture virale ?\nQuels symptômes nécessitent une culture virale urgente ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Drug+Utilization#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Culture virale",
"description": "Comment prévenir les infections virales ?\nLes vaccins sont-ils efficaces contre tous les virus ?\nQuelles mesures d'hygiène sont recommandées ?\nLes masques aident-ils à prévenir les infections virales ?\nLes voyages augmentent-ils le risque d'infection virale ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Drug+Utilization#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Culture virale",
"description": "Quels traitements sont disponibles pour les infections virales ?\nLa culture virale aide-t-elle à choisir un traitement ?\nLes antibiotiques sont-ils efficaces contre les virus ?\nComment les antiviraux agissent-ils ?\nLes traitements sont-ils les mêmes pour tous les virus ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Drug+Utilization#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Culture virale",
"description": "Quelles complications peuvent survenir après une infection virale ?\nLes complications sont-elles prévisibles ?\nComment les complications sont-elles traitées ?\nLes enfants sont-ils plus à risque de complications ?\nLes personnes âgées sont-elles plus vulnérables aux complications ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Drug+Utilization#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Culture virale",
"description": "Quels facteurs augmentent le risque d'infection virale ?\nL'âge influence-t-il le risque d'infection virale ?\nLes maladies chroniques augmentent-elles le risque ?\nLe mode de vie influence-t-il le risque d'infection virale ?\nLes voyages à l'étranger augmentent-ils le risque d'infection ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Drug+Utilization#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment se déroule un test de culture virale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un échantillon est inoculé sur un milieu de culture pour observer la croissance virale."
}
},
{
"@type": "Question",
"name": "Quels échantillons sont utilisés pour la culture virale ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les échantillons peuvent inclure du sang, des sécrétions respiratoires ou des biopsies."
}
},
{
"@type": "Question",
"name": "Quels tests complètent la culture virale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques et PCR sont souvent utilisés pour confirmer l'infection virale."
}
},
{
"@type": "Question",
"name": "Combien de temps prend une culture virale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La culture virale peut prendre de quelques jours à plusieurs semaines selon le virus."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une infection virale dans une culture ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'apparition de cytopathies ou de plaques de lyse indique une infection virale."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une infection virale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, toux, douleurs musculaires et éruptions cutanées sont fréquents."
}
},
{
"@type": "Question",
"name": "Les symptômes varient selon le virus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut provoquer des symptômes spécifiques selon son tropisme."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils avec une infection virale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver ou s'améliorer selon la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents lors d'une culture virale ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas nécessairement, certains virus peuvent être asymptomatiques lors de la culture."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent une culture virale urgente ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes graves comme une détresse respiratoire ou une méningite justifient une culture."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections virales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vaccination, hygiène des mains et éviter le contact avec des personnes infectées."
}
},
{
"@type": "Question",
"name": "Les vaccins sont-ils efficaces contre tous les virus ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque vaccin cible des virus spécifiques et leur efficacité varie."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et désinfecter les surfaces fréquemment touchées."
}
},
{
"@type": "Question",
"name": "Les masques aident-ils à prévenir les infections virales ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les masques réduisent la transmission des virus respiratoires."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infection virale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent exposer à de nouveaux virus et à des épidémies."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les infections virales ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux, les immunoglobulines et les traitements symptomatiques sont utilisés."
}
},
{
"@type": "Question",
"name": "La culture virale aide-t-elle à choisir un traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle permet d'identifier le virus et de déterminer la sensibilité aux antiviraux."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre les virus ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont efficaces que contre les infections bactériennes."
}
},
{
"@type": "Question",
"name": "Comment les antiviraux agissent-ils ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils inhibent la réplication virale ou modulent la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils les mêmes pour tous les virus ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque virus peut nécessiter un traitement spécifique selon sa biologie."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une infection virale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme la pneumonie, la méningite ou des syndromes post-viraux peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prévisibles selon le virus et l'état de santé du patient."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles traitées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la complication, allant des soins de soutien à des interventions spécifiques."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque de complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains virus peuvent entraîner des complications plus graves chez les enfants."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus vulnérables aux complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un système immunitaire affaibli, augmentant le risque de complications."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'infection virale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un système immunitaire affaibli, le stress, et des conditions de vie insalubres augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'infection virale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées sont plus susceptibles aux infections virales."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète ou les maladies pulmonaires augmentent le risque d'infection."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque d'infection virale ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque d'infection ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones endémiques expose à des virus non rencontrés localement."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 08/03/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
2The Biodesign Center of Fundamental and Applied Microbiomics, School of Life Sciences, Center for Evolution and Medicine, Arizona State University, 1001 S. McAllister Ave, Tempe, AZ 85287-5001 USA.
3Structural Biology Research Unit, Department of Integrative Biomedical Sciences, University of Cape Town, Observatory, Cape Town, South Africa.
Publications dans "Culture virale" :
2 publications dans cette catégorie
Affiliations :
Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy.
Department of Mechanical, Chemical and Materials Engineering, University of Cagliari, Via Marengo 2, 09123 Cagliari, Italy.
Publications dans "Culture virale" :
2 publications dans cette catégorie
Affiliations :
Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy.
Department of Mechanical, Chemical and Materials Engineering, University of Cagliari, Via Marengo 2, 09123 Cagliari, Italy.
Publications dans "Culture virale" :
2 publications dans cette catégorie
Affiliations :
Department of Life and Environmental Sciences, University of Cagliari, 09042 Cagliari, Italy.
Publications dans "Culture virale" :
2 publications dans cette catégorie
Affiliations :
Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy.
Department of Mechanical, Chemical and Materials Engineering, University of Cagliari, Via Marengo 2, 09123 Cagliari, Italy.
Center for Advanced Studies, Research and Development in Sardinia (CRS4), Loc. Piscina Manna, Building 1, 09050 Pula, Italy.
Publications dans "Culture virale" :
2 publications dans cette catégorie
Affiliations :
Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy.
Department of Mechanical, Chemical and Materials Engineering, University of Cagliari, Via Marengo 2, 09123 Cagliari, Italy.
Publications dans "Culture virale" :
2 publications dans cette catégorie
Affiliations :
Bioprocess Engineering and AlgaePARC, Wageningen University and Research, Wageningen, Netherlands.
Biosciences and Aquaculture, Nord University, Bodø, Norway.
Publications dans "Culture virale" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Microbiology, Wageningen University & Research, Wageningen, Netherlands.
Publications dans "Culture virale" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Microbiology, Wageningen University & Research, Wageningen, Netherlands.
Publications dans "Culture virale" :
2 publications dans cette catégorie
Affiliations :
Horticulture and Product Physiology, Department of Plant Sciences, Wageningen University, Wageningen, Netherlands.
Publications dans "Culture virale" :
1 publication dans cette catégorie
Affiliations :
Department of Food Science, Center for Food Safety, University of Arkansas System Division of Agriculture, Fayetteville, AR 72704, United States of America; College of Life Science, Qingdao University, Qingdao, PR China.
Publications dans "Culture virale" :
1 publication dans cette catégorie
Affiliations :
Department of Food Science, Center for Food Safety, University of Arkansas System Division of Agriculture, Fayetteville, AR 72704, United States of America. Electronic address: keg005@uark.edu.
Publications dans "Culture virale" :
1 publication dans cette catégorie
Affiliations :
Unité de Biologie Moléculaire du Gène chez les Extrêmophiles, Département de Microbiologie, Institut Pasteur, Paris, 75015, France.
Publications dans "Culture virale" :
1 publication dans cette catégorie
Affiliations :
Univ Rennes, CNRS, IGDR (Institut de génétique et développement de Rennes) - UMR 6290, F-35000, Rennes, France.
Publications dans "Culture virale" :
1 publication dans cette catégorie
Affiliations :
Department of Energy Joint Genome Institute, Walnut Creek, CA, 94598, USA.
Publications dans "Culture virale" :
1 publication dans cette catégorie
Affiliations :
Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé environnement et travail)-UMR_S 1085, PROTIM, F-35000, Rennes, France.
Publications dans "Culture virale" :
1 publication dans cette catégorie
Affiliations :
Departamento de Producción Vegetal y Microbiología, Evolutionary Genomics Group, Universidad Miguel Hernandez, Alicante, 03550, Spain.
Publications dans "Culture virale" :
1 publication dans cette catégorie
Affiliations :
Department of Microbiology, The Ohio State University, Columbus, OH, 43210, USA.
Department of Civil, Environmental and Geodetic Engineering, The Ohio State University, Columbus, OH, 43210, USA.
Publications dans "Culture virale" :
1 publication dans cette catégorie
Affiliations :
Univ Rennes, CNRS, IGDR (Institut de génétique et développement de Rennes) - UMR 6290, F-35000, Rennes, France.
Publications dans "Culture virale" :
1 publication dans cette catégorie
Affiliations :
Unité de Biologie Moléculaire du Gène chez les Extrêmophiles, Département de Microbiologie, Institut Pasteur, Paris, 75015, France.
Publications dans "Culture virale" :
Medicare Part D has significantly enhanced access to prescription drugs among Medicare beneficiaries. However, the recent rapid rise of utilization management policies in the Medicare Part D program m...
To describe trends in and characteristics of sedative drug use from 2000 through 2019 in relation to the introduction of central regulations and new drugs....
In this descriptive study, we used individual prescription data on the entire Danish population from the Danish National Prescription Registry to calculate yearly incidence and prevalence of use of be...
The use of benzodiazepines and Z-drugs declined gradually from 2000 through 2019, whereas the newer alternatives, melatonin, low-dose quetiapine, pregabalin and promethazine, increased in use, while t...
In Denmark different central regulations have influenced prescription practice toward more restrictive use of Z-drugs and benzodiazepines, except for hypnotic benzodiazepine prescriptions increased af...
This proposed scoping review aims to examine studies assessing the impact of drug shortages on population-level drug utilization trends. The objectives of this review are to a) assess which drugs have...
Drug shortages continue to impair drug access and delivery of quality care across the world. However, the impact of drug supply disruptions on availability and drug use are understudied in current lit...
Published and unpublished observational studies reporting on the effects of drug supply chain disruptions (shortages, discontinuations, and safety-based withdrawals) on consequent utilization trends f...
The search strategy will combine two key search concepts: drug shortages and drug utilization. The search will be conducted in MEDLINE and EMBASE. This will be followed by an extensive grey literature...
Review registration number: Open Science Framework, https://osf.io/2p6e5....
We describe the distribution of prescribers responsible for opioid initiation and maintenance (general practice, hospital prescribers and other prescribers) in Denmark....
We leveraged data on opioid fills from a 20% sample of all Danes alive during 2000-2021....
Overall, general practitioners were responsible for most treatment initiation (74% during 2000-2021) and maintenance treatment (92%). However, while hospital prescribers initiated ≈20% of treatments d...
General practice prescribes most opioids; however, hospital prescribers are increasingly responsible for opioid prescribing, in particular initiation of morphine and oxycodone....
The burden of chronic myeloid leukaemia (CML) is increasing due to longer patient survival, better life expectancy of the general population, and increasing drug prices. Funding is one of the main con...
Patients with CML were recruited from outpatient haematological clinics at the national centre of intervention and referral for haematological conditions and a public teaching hospital. The health-rel...
Of the 221 respondents in this study, 68.8% were imatinib users. The total care provider cost for CML treatment was USD23,014.40 for imatinib and USD43,442.69 for nilotinib. The governmental financial...
Overall, imatinib is more cost-effective than nilotinib for treating CML in Malaysia from the care provider's perspective. The findings demonstrate the importance of cancer drug funding assistance for...
Drug utilization studies are essential to facilitate rational drug use in the society....
In this review, we provide an overview of drug utilization measures that can be used with individual-level drug dispensing data, referencing additional reading on the individual analysis. This is inte...
We provide an overview of: (1) basic measures of drug utilization which are used to describe changes in drug use over time or compare drug use in different populations; (2) treatment adherence measure...
The use of drug utilization management techniques such as formulary exclusions, prior authorizations, and step edits has risen sharply during the last decade, contributing to the growing burden on phy...
Antidepressant drugs are the most frequently prescribed medication for mental disorders. They are also used off-label and for non-psychiatric indications. Prescriptions of antidepressants have increas...
We will conduct a systematic review to estimate the prevalence of antidepressant use in the community. We will search for studies published from 1 January 2010 in the Embase and MEDLINE databases usin...
Ethical approval is not required for this review as it will not directly involve human or animal subjects. The findings of our systematic review will be disseminated through publications in peer-revie...
CRD42021247423....
Prolonged systemic antibiotic treatment is often a part of management of hidradenitis suppurativa (HS). Although biologic therapies are now available, the patient's treatment journey leading to biolog...
To examine treatment patterns and duration of systemic treatment use in patients with HS preceding biologic therapy....
We identified all patients with HS receiving treatment with biologics in the Danish National Patient Registry from 2010 to 2018 and extracted their entire prescription history of specific systemic tre...
A total of 225 patients with HS were included. Patients had most frequently been treated with penicillin (n = 214; 95·1%), dicloxacillin (n = 194; 86·2%), tetracycline (n = 145; 64·4%) and rifampicin/...
Patients with HS who receive biologic therapy have long preceding treatment histories with multiple drug classes and treatment series, many of which are supported by relatively weak evidence in HS. De...
Prescription drug costs have risen considerably in the United States and are projected to reach $560 billion by 2028....
To evaluate brand and generic drug utilization and cost proportions within Medicare Part D....
Prescription data for dermatology providers were obtained from the Centers for Medicare and Medicaid Services 2013-2019 Medicare Part D Prescribers by Provider datasets. Percentage of brand vs. generi...
The proportion of brand drug claims increased from 7.4% (in 2013) to 10.5% (2019) with a CAGR of 8.66%. In comparison, generic drug claims increased at a lower rate (CAGR 4.47%). The percentage of bra...
Inability to assess and generalize data for prescription patterns under non-Medicare plans....
Our study demonstrates a disproportionate rise in dermatologic brand drug claims and a substantial increase in costs associated with brand drugs. Brand-name drugs are associated with higher out-of-poc...